Treace Medical Concepts, Inc.
TMCI
$2.78
-$0.06-1.94%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 6.38% | -9.27% | -3,078.04% | 96.74% | 27.57% |
| Total Depreciation and Amortization | 7.84% | 4.67% | 98.95% | -42.65% | 1.94% |
| Total Amortization of Deferred Charges | 1.35% | 0.00% | -93.12% | 1,352.70% | 0.00% |
| Total Other Non-Cash Items | -11.73% | 3.31% | -10.12% | 50.87% | -19.90% |
| Change in Net Operating Assets | -413.29% | -80.66% | 145.29% | -183.53% | -50.83% |
| Cash from Operations | -198.10% | -172.65% | 199.79% | 64.47% | 14.79% |
| Capital Expenditure | 41.07% | -34.55% | -15.26% | -7.37% | -65.59% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 664.57% | -8.43% | -74.61% | -24.70% | -64.30% |
| Cash from Investing | 368.22% | -71.96% | -155.36% | -40.64% | -74.31% |
| Total Debt Issued | -42.01% | -- | -- | -- | -- |
| Total Debt Repaid | -317.35% | -- | -- | -- | -- |
| Issuance of Common Stock | 107.76% | -2.52% | 108.77% | 612.50% | -97.43% |
| Repurchase of Common Stock | -2,842.86% | 96.51% | -1,193.55% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -101.01% | 450.00% | -1,184.62% | 225.00% | -97.43% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 93.12% | -363.11% | 366.05% | 87.48% | -168.62% |